Exane Derivatives’s Coherent COHR Stock Holding History

Exane Derivatives’s Portfolio COHR Stock Details COHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,183	Closed	-$303K	–	830
2022 Q1	$303K	Buy	+4,183	New	+$285K	0.09%	246
2021 Q4	–	Sell	-5,936	Closed	-$352K	–	897
2021 Q3	$352K	Hold	5,936	–	–	0.08%	252
2021 Q2	$425K	Hold	5,936	–	–	0.1%	219
2021 Q1	$406K	Buy	+5,936	New	+$487K	0.12%	172

Other funds holding COHR

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Exane Derivatives's COHR Position: Q2 2022 in Review

Exane Derivatives sold out of Coherent (COHR) in Q2 2022, closing a stake of 4,183 shares — an estimated $303K sold.

Exane Derivatives first reported a position in COHR in Q1 2021 and held it in 4 quarters. The position peaked at $425K in Q2 2021. 448 funds tracked by Wall St. Rank hold COHR as of Q2 2022.

Exane Derivatives reported no remaining Coherent position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 4,183 Coherent shares in Q2 2022, an estimated $303K.
Exane Derivatives first reported a position in Coherent in Q1 2021 and held it in 4 quarters.
Exane Derivatives's Coherent position peaked at $425K in Q2 2021.
448 funds tracked by Wall St. Rank held Coherent as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.